Innovation Pharmaceuticals Inc (IPIX)

[GreenBioAnalyst]

With a small grant, IND, one Phase II, and peer-review, we are looking at $2ish with 600mc to 700m mc valuation.

Imagine if NIH decides to grant $60m to 80mil? That's $1.3b or
$4ish?

Then raise another $100mil through PPF, expand clinical trial, pushes our valuation to about $2.3b, and get uploaded to NASDAQ and have at least four cv19 stages all in phase II.

Buy and hold. Accumulate. Investing in Bril drug as the n flagship is a risk-free investment with the company trading below $3 to $5b in the next 9 to 12 months. Jmo.

The short-term catalyst not inclusive of the projected $2.3b asks is a partnership and additional funding from B's OM initiation of Phase III.

Go big, buy, accumulate, and hold to on to your shares!